Table 8.
Honey | Dose | Duration | Subjects | Physiological Parameter | Effect | Reference |
---|---|---|---|---|---|---|
Low- and high- antioxidant buckwheat honey from the Dutch Gold company | 1.5 g/kg | 6 h | Healthy subjects 25.55 ± 2.30 years |
Plasma phenolic concentration | ↑ * | [56] |
Plasma antioxidant capacity | ↑ * | |||||
Plasma reducing capacity | ↑ * | |||||
Manuka honey from New Zealand | Manuka honey microemulsion cream 0.5–1 cm Once a day |
3 m | Patients with blepharitis 60 ± 12 years |
Dry eye symptomology | ↓ a | [57] |
Tear film quality | ↑ a | |||||
Ocular surface quality | ↑ a | |||||
Microbial burden | ↓ a | |||||
Local unpasteurized honey from Honeycomb Apiairies, Bristol and filtered pasteurized clover honey from Dutch Gold Honey Inc, Lancaster | 1 tablespoonful/d | 30 w | Patients with allergic rhinoconjunctivitis 45.3 years |
Symptoms of rhinoconjunctivitis | = | [58] |
Multiflora honey and Manuka honey UMF 20+, both produced by Comvita New Zealand Ltd. | 20 g/d | Crossover 4 w each period |
Healthy subjects 42–64 years |
IgE level | ↑ | [59] |
Gut bacterial | = | |||||
Astragalus honey made in Ashtian Region of Iran | 1.2 g/kg from the 15th day to the onset of menstruation | Crossover 2 m each period |
Female students with dysmenorrhea 22.01 ± 1.78 years |
Pain | = | [60] |
Amount of bleeding | = | |||||
Satisfaction | = |
h: hour; d: day; w: week; m: month; ↑: increase; ↓: decrease; =: unchanged. * Significant differences (p < 0.05) within group between baseline and the end. a Significantly different (p < 0.05) from the control group.